There's a scientific breakthrough in your medicine cabinet. But how did it get there?
At a time when medicines are helping us all live longer and healthier lives, this podcast will explore where these taken-for-granted miracles come from, how many of them almost never happened, where the life science ecosystem is taking us next, and most importantly, what it means for patients.
From chance meetings that led to new ideas, to risky investments that never pay off, hear from the people behind today's and tomorrow's treatments, vaccines, technologies, devices, and yes, cures.
In this golden age of health discovery and innovation fueled by record breaking investment in the life sciences, we'll bring guests who really understand what it means to be Making Medicine.
All content for Making Medicine is the property of Incubate Coalition and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
There's a scientific breakthrough in your medicine cabinet. But how did it get there?
At a time when medicines are helping us all live longer and healthier lives, this podcast will explore where these taken-for-granted miracles come from, how many of them almost never happened, where the life science ecosystem is taking us next, and most importantly, what it means for patients.
From chance meetings that led to new ideas, to risky investments that never pay off, hear from the people behind today's and tomorrow's treatments, vaccines, technologies, devices, and yes, cures.
In this golden age of health discovery and innovation fueled by record breaking investment in the life sciences, we'll bring guests who really understand what it means to be Making Medicine.
Boston Biotech Pulse: Shutdowns, Pfizer Deal, and the Future of Innovation
Making Medicine
11 minutes
1 month ago
Boston Biotech Pulse: Shutdowns, Pfizer Deal, and the Future of Innovation
In this week’s episode, John Stanford reports from Boston - the beating heart of global biotech - with insights from investors, scientists, and executives shaping the future of life sciences. He breaks down what the government shutdown means for FDA operations, unpacks the White House–Pfizer deal, and shares key takeaways from conversations on U.S. competitiveness, biotech investment, and the next generation of talent and technology.
How do you see policy uncertainty affecting biotech innovation? Are U.S. policies doing enough to keep the next generation of scientists here? What biotech breakthroughs excite you most right now?
If you're new to the Making Medicine Podcast, we're happy you're here! Follow us for more:https://x.com/MakingMedPodhttps://www.instagram.com/makingmedicinepod/https://www.linkedin.com/showcase/making-medicine-podcast/about/?viewAsMember=true
Timestamps: 0:00 Disclaimer: Not medical or investment advice 0:23 Welcome from Boston - biotech capital of the world 1:11 Government shutdown and FDA operations 2:06 What’s paused at the FDA and why it matters 2:29 Understanding the White House–Pfizer deal 3:19 MFN pricing, TrumpRx, and tariff waivers 4:07 Pfizer’s $70B U.S. investment and industry implications 4:29 Key takeaways from Boston investor meetings 4:58 Policy uncertainty and its impact on biotech investment 5:29 Interest rate cuts and biotech’s comeback potential 6:07 The growing threat to U.S. scientific talent 6:33 The “brain drain” and its implications for America’s biotech future 7:22 Boston’s role in championing life sciences 7:50 Exciting new biotech modalities: gene therapy, RNA, and cell engineering 9:34 Policy clarity, workforce development, and scientific momentum 10:20 Closing thoughts: innovation across America 10:40 Outro and call to action
DISCLAIMER: We’re reporting on the headlines, not making medical recommendations. For personal health questions, always consult a doctor.
Making Medicine
There's a scientific breakthrough in your medicine cabinet. But how did it get there?
At a time when medicines are helping us all live longer and healthier lives, this podcast will explore where these taken-for-granted miracles come from, how many of them almost never happened, where the life science ecosystem is taking us next, and most importantly, what it means for patients.
From chance meetings that led to new ideas, to risky investments that never pay off, hear from the people behind today's and tomorrow's treatments, vaccines, technologies, devices, and yes, cures.
In this golden age of health discovery and innovation fueled by record breaking investment in the life sciences, we'll bring guests who really understand what it means to be Making Medicine.
